Financhill
Back

Genmab A/S Quote, Financials, Valuation and Earnings

Sell
45

GMAB
Genmab A/S

Last Price:
29.96
Seasonality Move:
9.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Genmab A/S Price Quote

$29.96
+0.31 (+1.05%)
(Updated: May 17, 2024 at 6:50 PM ET)

Genmab A/S Key Stats

Sell
45
Genmab A/S (GMAB) is a Sell

Day range:
$29.50 - $29.83
52-week range:
$26.32 - $42.72
Dividend yield:
0%
P/E ratio:
30.93
P/S ratio:
7.55
P/B ratio:
4.07%

Volume:
587.5K
Avg. volume:
485.2K
1-year change:
-28.64%
Market cap:
$19.2B
Revenue:
$2.4B
EPS:
$1.21

How Much Does Genmab A/S Make?

  • How Much Are Genmab A/S's Sales Annually?
    GMAB Revenues are $2.4B
  • How Much Profit Does Genmab A/S's Make A Year?
    GMAB net income is $631.9M

Is Genmab A/S Growing As A Company?

  • What Is Genmab A/S's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Genmab A/S's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 5.39%

Genmab A/S Stock Price Performance

  • Did Genmab A/S Stock Go Up Last Month?
    Genmab A/S share price went up by 0.75% last month
  • Did GMAB's Share Price Rise Over The Last Year?
    GMAB share price fell by -28.64% over the past 1 year

What Is Genmab A/S 52-Week High & Low?

  • What Is Genmab A/S’s 52-Week High Share Price?
    Genmab A/S has traded as high as $42.72 over the past 52 weeks
  • What Is Genmab A/S’s 52-Week Low Share Price?
    Genmab A/S has traded as low as $26.32 over the past 52 weeks

Genmab A/S Price To Free Cash Flow

Is It Risky To Buy Genmab A/S?

  • How Much Debt Does Genmab A/S Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Genmab A/S Have?
    Cash and short term investments quarterly total is $4.3B
  • What Is Genmab A/S’s Book Value Per Share?
    Book value per share is 7.22

Is Genmab A/S Cash Flow Positive?

  • What Is GMAB Cash Flow From Operations?
    Cash flow from operations (TTM) is $825.3M
  • What Is Genmab A/S’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$86.5M
  • What Is Genmab A/S’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$394.1M

Genmab A/S Return On Invested Capital

  • Is Management Doing A Good Job?
    GMAB return on invested capital is 18.08%
  • What Is Genmab A/S Return On Assets?
    ROA measures how assets are converting to revenues and is 16.12%
  • What Is GMAB Return On Equity?
    ROE is a measure of profitability and is 18.08%

Genmab A/S Earnings Date & Stock Price

  • What Is Genmab A/S's Stock Price Today?
    A single share of GMAB can be purchased today for 29.65
  • What Is Genmab A/S’s Stock Symbol?
    Genmab A/S trades on the nasdaq under the ticker symbol: GMAB
  • When Is Genmab A/S’s Next Earnings Date?
    The next quarterly earnings date for Genmab A/S is scheduled on August 1, 2024
  • When Is GMAB's next ex-dividend date?
    Genmab A/S's next ex-dividend date is May 18, 2024
  • How To Buy Genmab A/S Stock?
    You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Genmab A/S Competitors

  • Who Are Genmab A/S's Competitors?
    Below is a list of companies who compete with Genmab A/S or are related in some way:
    • Ascendis Pharma A/S (ASND)
    • Evaxion Biotech AS (EVAX)
    • Galecto Inc (GLTO)
    • IO Biotech Inc (IOBT)
    • Novo Nordisk A/S (NVO)

Genmab A/S Dividend Yield

Data Unavailable

Genmab A/S Analyst Estimates

YoY Growth Past Surprise
EPS: 538.94% 61.17%
Revenue: 47.65% 4.68%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 39.78
Upside from Last Price: 34.16%

Major Shareholders

  • How many GMAB shares are owned by institutional investors?
    62.7M GMAB shares are owned by institutional investors
  • How many GMAB shares are owned by insiders?
    0 GMAB shares are owned by insiders